SPPI earnings call for the period ending March 31, 2019.
News & Analysis: Spectrum Pharmaceuticals
SPPI earnings call for the period ending December 31, 2018.
More retail struggles sent the department store giant lower.
The biopharma announced that one of its drug candidates is closer to hitting the market, but investors aren't in a celebratory mood.
Bad news for an experimental lung cancer therapy didn't go down well with investors.
The company announced third-quarter 2018 earnings and a pipeline update, but investors weren't happy with results from an important trial announced in early December.
Shares jumped even though second-quarter results were mixed. What's going on?
Shares jump after rumors that the biotech is looking to sell itself. Here's what investors need to know.
Shares jumped after the company shared new details from an important phase 3 study. Here's what investors need to know.
Can these red-hot biotech stocks keep the momentum going?